Hepion Pharmaceuticals
fibrosis associated gene network observed in phase a blood samples supports efficacy in day study expression related to coset ies so | Hepion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
21 of 34
Related slides by other companies
Xeris Biopharma
Investor Presentation
October 2022
topline results of phase study of | Xeris Biopharma
ATAI
Investor Presentation
October 2022
phase a study showed wide spread beneficial changes | ATAI
Teknova
IPO
June 2021
there is significant opportunity as cell gene therapy customers scale through clinical phases | Teknova
Genprex
Investor Presentation
November 2024
program highlights | Genprex
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io